SLC1A2 and early-onset autosomal dominant Alzheimer disease: The loss of EAAT2 is involved in the development of CNS neurodegenerative diseases, such as Alzheimer’s disease and Huntington’s disease, and peripheral spinal cord motor neuropathies, such as amyotrophic lateral sclerosis (ALS) (Yi and Hazell, 2006).